4581 — Taisho Pharmaceutical Holdings Co Share Price
0.000.00%
Last trade - 00:00- ¥704bn
- ¥463bn
- ¥301bn
- 72
- 35
- 96
- 82
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 38.9 | ||
| PEG Ratio (f) | 1.13 | ||
| EPS Growth (f) | 52.72% | ||
| Dividend Yield (f) | 1.16% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.85 | ||
| Price to Tang. Book | 1.2 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.2 | ||
| EV to EBITDA | 10.81 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 1.22% | ||
| Return on Equity | 1.04% | ||
| Operating Margin | 3.51% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 261,551 | 288,527 | 281,980 | 268,203 | 301,381 | 321,750 | 326,250 | 1.48% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -3.38 | -31.33 | +4.19 | -6.35 | +28.6 | -57.51 | +52.72 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Taisho Pharmaceutical Holdings Co Ltd is a Japan-based company mainly engaged in the research, development, manufacture and sale of over-the-counter drugs, quasi-drugs, foods, medical supplies, hygiene products, and ethical drugs. The Company operates in two business segments. The Self-Medication segment is engaged in the research, development, manufacture and sale of over-the-counter drugs, quasi-drugs, foods, medical supplies, hygiene products. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of ethical drugs. The other business is engaged in the leasing and management of real estate, as well as hotel management business.
Directors
- Akira Uehara PRE (80)
- Takeshi Ishiguro FID
- Osamu Kitatani CEX (62)
- Ken Uehara CEX (43)
- Shigeru Uehara VPR (45)
- Jun Kuroda DRC (64)
- Tetsu Watanabe DRC (67)
- Takeshi Kunibe IND (67)
- Hiroyuki Uemura IND (79)
- Last Annual
- March 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- October 3rd, 2011
- Public Since
- October 3rd, 2011
- No. of Shareholders
- 27,410
- No. of Employees
- 8,784
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 81,967,464
- Address
- 3-24-1, Takada, TOSHIMA-KU, 170-8655
- Web
- https://www.taisho-holdings.co.jp/
- Phone
- +81 339852020
- Auditors
- Ernst & Young ShinNihon LLC
Upcoming Events for 4581
Full Year 2024 Taisho Pharmaceutical Holdings Co Ltd Earnings Release
Q1 2025 Taisho Pharmaceutical Holdings Co Ltd Earnings Release
Similar to 4581
ASKA Pharmaceutical Holdings Co
Tokyo Stock Exchange
Astellas Pharma
Tokyo Stock Exchange
Astena Holdings Co
Tokyo Stock Exchange
CanBas Co
Tokyo Stock Exchange
CellSeed
Tokyo Stock Exchange
FAQ
What is the Taisho Pharmaceutical Holdings Co share price?
As of Today at 19:21 UTC, shares in Taisho Pharmaceutical Holdings Co are trading at ¥8,590. This share price information is delayed by 15 minutes.
How has the Taisho Pharmaceutical Holdings Co share price performed this year?
Shares in Taisho Pharmaceutical Holdings Co last closed at ¥8,590 and the price had moved by +51.77% over the past 365 days. In terms of relative price strength the Taisho Pharmaceutical Holdings Co share price has outperformed the Nikkei 225 Index by +4.83% over the past year.
What are the analyst and broker recommendations for Taisho Pharmaceutical Holdings Co?
The overall consensus recommendation for Taisho Pharmaceutical Holdings Co is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Taisho Pharmaceutical Holdings Co dividend yield?
The Taisho Pharmaceutical Holdings Co dividend yield is 1.16% based on the trailing twelve month period.
Does Taisho Pharmaceutical Holdings Co pay a dividend?
Last year, Taisho Pharmaceutical Holdings Co paid a total dividend of ¥100, and it currently has a trailing dividend yield of 1.16%. We do not have any data on when Taisho Pharmaceutical Holdings Co is to next pay dividends.
When does Taisho Pharmaceutical Holdings Co next pay dividends?
We do not have data on when Taisho Pharmaceutical Holdings Co is to next pay dividends. The historic dividend yield on Taisho Pharmaceutical Holdings Co shares is currently 1.16%.
How do I buy Taisho Pharmaceutical Holdings Co shares?
To buy shares in Taisho Pharmaceutical Holdings Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Taisho Pharmaceutical Holdings Co?
As of the previous close price of ¥8,590, shares in Taisho Pharmaceutical Holdings Co had a market capitalisation of ¥704bn.
Where are Taisho Pharmaceutical Holdings Co shares listed?
Here are the trading details for Taisho Pharmaceutical Holdings Co:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 4581
What kind of share is Taisho Pharmaceutical Holdings Co?
Based on an overall assessment of its quality, value and momentum Taisho Pharmaceutical Holdings Co is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Taisho Pharmaceutical Holdings Co share price forecast for 2024?
The analyst consensus target price for shares in Taisho Pharmaceutical Holdings Co is ¥5,600. That is 34.81% below the last closing price of ¥8,590.
Analysts covering Taisho Pharmaceutical Holdings Co currently have a consensus Earnings Per Share (EPS) forecast of ¥145 for the next financial year.
Find out moreWhat is the trend in the Taisho Pharmaceutical Holdings Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Taisho Pharmaceutical Holdings Co. Over the past six months, its share price has outperformed the Nikkei 225 Index by +13.2%.
As of the last closing price of ¥8,590, shares in Taisho Pharmaceutical Holdings Co were trading +22.47% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Taisho Pharmaceutical Holdings Co PE Ratio?
The Taisho Pharmaceutical Holdings Co PE ratio based on its reported earnings over the past 12 months is 38.9. The shares last closed at ¥8,590.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Taisho Pharmaceutical Holdings Co?
Taisho Pharmaceutical Holdings Co's management team is headed by:
- Akira Uehara - PRE
- Takeshi Ishiguro - FID
- Osamu Kitatani - CEX
- Ken Uehara - CEX
- Shigeru Uehara - VPR
- Jun Kuroda - DRC
- Tetsu Watanabe - DRC
- Takeshi Kunibe - IND
- Hiroyuki Uemura - IND